Alex Sapir
CIK 1709415 · See Remarks · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$667.1K
Companies
3
Total Filings
12
Lifetime Open-Market Net
$1.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FULC | See Remarks | 193,360 | $3.45 | $667.1K | $492.0K | 4 | 2026-02-04 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | — | $0.07 | — | $0 | 4 | 2022-05-20 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | President & CEO | 68,609 | — | — | $837.1K | 3 | 2018-08-15 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-27 | Dova Pharmaceuticals Inc. (DOVA) Delisted | Exer (M) | +26,809 | $100.0K | EDGAR |
| 2017-07-07 | Dova Pharmaceuticals Inc. (DOVA) Delisted | Buy (P) | +20,100 | $341.7K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.